MyAverix Finance
NS · Pharmaceuticals
Brooks Laboratories Ltd (BROOKS)
Pharmaceuticals & Biotechnology
Brooks Laboratories Ltd (BROOKS) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $2.17B, P/E ratio is 37.31, net margin is 4.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for BROOKS
Brooks Laboratories Ltd (BROOKS) — FAQ
What is Brooks Laboratories Ltd's market cap?
Brooks Laboratories Ltd (BROOKS) has a reported market cap of $2.17B (data as of 2026-07-10).
What is BROOKS's P/E ratio?
The price-to-earnings (P/E) ratio for Brooks Laboratories Ltd (BROOKS) is 37.31 (data as of 2026-07-10).
Does Brooks Laboratories Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Brooks Laboratories Ltd (BROOKS). Check the MyAverix Finance app for the latest dividend data.
What sector is Brooks Laboratories Ltd in?
Brooks Laboratories Ltd (BROOKS) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is BROOKS listed on?
BROOKS is listed on NS.
What is Brooks Laboratories Ltd's net margin?
Brooks Laboratories Ltd (BROOKS) reports a net margin of 4.1% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.